Expression of the functional recombinant human glycosyltransferase GalNAcT2 in Escherichia coli

BACKGROUND: Recombinant protein-based therapeutics have become indispensable for the treatment of many diseases. They are produced using well-established expression systems based on bacteria, yeast, insect and mammalian cells. The majority of therapeutic proteins are glycoproteins and therefore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauber, Jennifer, Handrick, René, Leptihn, Sebastian, Dürre, Peter, Gaisser, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299809/
https://www.ncbi.nlm.nih.gov/pubmed/25582753
http://dx.doi.org/10.1186/s12934-014-0186-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299809/
https://www.ncbi.nlm.nih.gov/pubmed/25582753
http://dx.doi.org/10.1186/s12934-014-0186-0

Ejemplares similares